- Sales of $4,029.8 million, up 1.3% and 1.6% when excluding the impact of IFRS 16
- Food same-store sales up 1.4%
- Pharmacy same-store sales up 3.6%
- Net earnings of $170.2 million, down 16.2%
- Adjusted net earnings(1) of $180.9 million, up 5.1%
- Fully diluted net earnings per share of $0.67, down 15.2%
- Adjusted fully diluted net earnings per share((1) of $0.71, up 6.0%
- Declared dividend of $0.225 per share, up 12.5%
- Dividend payout increase to a target range of 30% to 40% of the previous year's adjusted net earnings(1)
Please look at our Press Release (.pdf)
